Welspun Investments & Commercials Board Meeting Outcome

Welspun Investments & Commercials Q2 FY27 Results: Net Profit ₹8.8 Cr, Up 151.4% YoY

Welspun Investments & Commercials Ltd reported revenue from operations of ₹14.1 Cr (+187.8% YoY) and net profit of ₹8.8 Cr (+151.4% YoY) for Q2 FY27.

Key figure

Net profit ₹8.8 Cr · +151.4% YoY

Welspun Investments & Commercials Board Meeting Date

Welspun Investments and Commercials will hold a board meeting on 28 October 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from 1 October to 30 October 2026.

Welspun Investments & Commercials Other Announcement

The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.

Welspun Investments & Commercials Annual General Meeting

Welspun Investments and Commercials Limited held its 18th Annual General Meeting on September 30, 2026, where shareholders approved financial statements, director appointment, and a related party investment.

Welspun Investments & Commercials Annual General Meeting

Welspun Investments and Commercials Limited announced book closure from September 16 to September 18, 2026. This closure is for the purpose of the Annual General Meeting.

Welspun Investments & Commercials Acquisition

Welspun Investments and Commercials Ltd has completed its acquisition of a 100% stake in Vishwakarma Realty Private Limited. VRPL is now a wholly-owned subsidiary.

R R Kabel Board Meeting Outcome

RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.

M K Exim (India) Board Meeting Outcome

M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.

United Spirits Board Meeting Outcome

United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.

SBI Funds Management Board Meeting Outcome

SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.

Execution

April 1, 2028 to March 31, 2030

Paras Healthcare Board Meeting Outcome

Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.

Gateway Distriparks Board Meeting Outcome

Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.